Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The European Commission has clarified aspects of its next Framework programme of research. An insistence on quick delivery of socio-economic benefits threatens the programme's success.
President Bill Clinton's budget request for research falls short of the expectations of the scientific community, which have recently risen to unrealistic levels.
France's ‘contaminated blood’ trial is a reminder that witch-hunts, however well disguised in legal formalities, are no substitute for a credible, wide-ranging and dispassionate judicial inquiry.
The sharing of data by researchers ought to be encouraged. But a compulsion to release raw data and notes in current US openness laws is the wrong way to achieve it, as is a proposed amendment.
The relationship between Japan's universities and the education ministry is too undemanding to allow critical appraisal of research. Rigorous external evaluation must become the norm.
A quick legislative fix to the question of the use of federal funds for research with human embryo stem cells has been rightly resisted. But clear thinking and communication are needed if the research is to achieve its potential.
The SPD and Green coalition that governs Germany has made notable progress and demonstrated flexibility in the process. But the Greens' lack of expertise needs redressing if good science is to get the support it deserves.
Cultural, institutional, conceptual and linguistic barriers are being overcome as physicists and biologists recognize the scientific stimulus they can gain from each other. The United States is showing the way.
The need to place scientific knowledge at the heart of economic and social policy has underlined some of the limitations of focusing on trade liberalization. Developing countries should be a prime beneficiary.